4552 — JCR Pharmaceuticals Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for JCR Pharmaceuticals Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	26,260	30,977	13,278	18,756	13,196
Net Total Accounts Receivable
Net Total Receivables	8,183	15,585	11,137	14,934	12,236
Total Inventory
Total Other Current Assets
Total Current Assets	48,545	62,188	47,802	57,581	51,056
Net Property, Plant And Equipment	17,172	26,782	32,681	30,040	37,410
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	73,784	97,134	94,937	102,226	104,855
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	29,028	42,054	35,762	30,135	43,988
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	35,401	46,250	42,775	46,048	57,814
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	38,383	50,884	52,162	56,178	47,041
Total Liabilities & Shareholders' Equity	73,784	97,134	94,937	102,226	104,855
Total Common Shares Outstanding